
Meds After Acute Coronary Syndrome
Listen in as our expert panel discusses the latest recommendations for managing medications after heart attacks and other cardiac events. You’ll hear our panelists review which antiplatelets to use, t...
1 Syys 202532min

HIV Prevention: A Guide to PrEP and PEP
Listen in as we explore the latest pharmacologic strategies for HIV prevention—before and after exposure. Our expert panel breaks down key considerations for PrEP and PEP, including indications, drug ...
1 Elo 202538min

Antidepressant Insights
Listen in as our expert panel discusses practical considerations for starting and optimizing antidepressants for treating depression and anxiety. You’ll listen to panelists cover various aspects of a...
1 Heinä 202538min

Meds for Alzheimer Dementia
Listen in as our expert panel discusses medications for the treatment of Alzheimer dementia. They'll review the risks and benefits of cholinesterase inhibitors, memantine, and the anti-amyloid monocl...
1 Kesä 202534min

Medications for Opioid Use Disorder
Listen in as our expert panel discusses medications for management of opioid use disorder. They’ll review strategies to optimize buprenorphine use and clarify the role of methadone and naltrexone. Spe...
1 Touko 202537min

Cardiovascular Impact of Diabetes Meds
Listen in as our expert panel discusses which diabetes meds have cardiovascular (CV) benefits. We’ll review the evidence and discuss the pros and cons of SGLT2 inhibitors (dapagliflozin, empagliflozi...
1 Huhti 202536min

Bronchitis and Pneumonia Treatment
In this episode, listen in as our expert panel digs into identifying and treating acute bronchitis and community-acquired pneumonia. They’ll discuss when antibiotics are appropriate, which antibiotics...
1 Maalis 202534min

Notable New Meds of 2024
In this episode, TRC Healthcare editors, Sara Klockars, PharmD, BCPS, and Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC, discuss notable new meds of 2024. Listen in as our editors discuss several n...
1 Helmi 202531min





















